{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T23:44:05Z","timestamp":1783727045207,"version":"3.55.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2008,1,8]],"date-time":"2008-01-08T00:00:00Z","timestamp":1199750400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1007\/s10067-007-0812-x","type":"journal-article","created":{"date-parts":[[2008,1,7]],"date-time":"2008-01-07T03:49:16Z","timestamp":1199677756000},"page":"517-519","source":"Crossref","is-referenced-by-count":18,"title":["Clinical significance of anti-Ro antibodies in rheumatoid arthritis"],"prefix":"10.1007","volume":"27","author":[{"given":"Emilce","family":"Schneeberger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Citera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Heredia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Maldonado Cocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,1,8]]},"reference":[{"issue":"2","key":"812_CR1","first-page":"85","volume":"65","author":"O Meyer","year":"1998","unstructured":"Meyer O (1998) Anti-Ro (SS-A). Rev Rhum (Engl Ed) 65(2):85\u201388","journal-title":"Rev Rhum (Engl Ed)"},{"key":"812_CR2","first-page":"1838","volume":"23","author":"P Bouffard","year":"1996","unstructured":"Bouffard P, Laniel M-A, Boire G (1996) Anti-Ro (SSA) antibodies: clinical significance and biological relevance. J Rheumatol 23:1838\u20131841","journal-title":"J Rheumatol"},{"key":"812_CR3","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/rheumatology\/32.5.396","volume":"32","author":"E Ben-Chetrit","year":"1993","unstructured":"Ben-Chetrit E (1993) The molecular basis of the SSA\/Ro antigens and the clinical significance of their antibodies. Br J Rheumatol 32:396\u2013402","journal-title":"Br J Rheumatol"},{"key":"812_CR4","first-page":"1654","volume":"20","author":"G Boire","year":"1993","unstructured":"Boire G, M\u00e9nard H-A, Gendron M, Lussier A, Myhal D (1993) Rheumatoid arthritis: anti-Ro antibodies define a non-HLA-DR4 associated clinicoserological cluster. J Rheumatol 20:1654\u20131660","journal-title":"J Rheumatol"},{"key":"812_CR5","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0896-8411(88)90008-X","volume":"3","author":"FN Skopouli","year":"1988","unstructured":"Skopouli FN, Andonopoulos AP, Moutsopoulos HM (1988) Clinical implication of the presence of anti-Ro (SSA) antibodies in patients with rheumatoid arthritis. J Autoimmun 3:381\u2013388","journal-title":"J Autoimmun"},{"key":"812_CR6","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3109\/03009748509102067","volume":"56","author":"R Smeenk","year":"1985","unstructured":"Smeenk R, Westgeest T, Swaak T (1985) Antinuclear antibody determination: The present state of diagnostic and clinical relevance. Scand J Rheumatol Suppl 56:78\u201392","journal-title":"Scand J Rheumatol Suppl"},{"key":"812_CR7","first-page":"391","volume":"15","author":"G Boire","year":"1988","unstructured":"Boire G, M\u00e9nard H-A (1988) Clinical significance of anti-Ro (SSA) antibody in rheumatoid arthritis. J Rheumatol 15:391\u2013394","journal-title":"J Rheumatol"},{"key":"812_CR8","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1987","unstructured":"Arnett FC, Edworthy SM, Bloch DA et al (1987) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315\u2013324","journal-title":"Arthritis Rheum"},{"key":"812_CR9","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1001\/archinte.1988.00380070117028","volume":"148","author":"RS Panush","year":"1988","unstructured":"Panush RS, Edwards SM, Longley S, Webster E (1988) \u201cRhupus\u201d syndrome. Arch Intern Med 148:1633\u20131636","journal-title":"Arch Intern Med"},{"key":"812_CR10","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3109\/03009747309098833","volume":"2","author":"A Larsen","year":"1973","unstructured":"Larsen A (1973) Radiological grading of rheumatoid arthritis: an interobserver study. Scand J Rheumatol 2:136\u2013138","journal-title":"Scand J Rheumatol"},{"key":"812_CR11","first-page":"234","volume":"19","author":"M Tishler","year":"1992","unstructured":"Tishler M, Moutsopoulos HM, Yaron M (1992) Genetic studies of anti-Ro (SSA) antibodies in families with rheumatoid arthritis. J Rheumatol 19:234\u2013236","journal-title":"J Rheumatol"},{"key":"812_CR12","first-page":"1040","volume":"21","author":"M Tishler","year":"1994","unstructured":"Tishler M, Golbrut B, Shoenfeld Y, Yaron M (1994) Anti-Ro (SSA) antibodies in patients with rheumatoid arthritis a possible marker for gold induced side effects. J Rheumatol 21:1040\u20131042","journal-title":"J Rheumatol"},{"key":"812_CR13","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s002960050023","volume":"17","author":"M Tishler","year":"1997","unstructured":"Tishler M, Nyman J, Wahren M, Yaron M (1997) Anti-Ro (SSA) antibodies in rheumatoid arthritis patients with gold-induced side effects. Rheumatol Int 17:133\u2013135","journal-title":"Rheumatol Int"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-007-0812-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-007-0812-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-007-0812-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T04:51:11Z","timestamp":1559105471000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-007-0812-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,8]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["812"],"URL":"https:\/\/doi.org\/10.1007\/s10067-007-0812-x","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,8]]}}}